Hedgehogs Host the Evolution of Antibiot...

In this episode of Science Quickly, journalist Michael Pollan joins Scientific American’s Bri Kane to unpack why consciousness is so hard to define in a discussion that explores what brain science, artificial intelligence experiments and even psychedelics might reveal about how a ... Show More

In February the BBC’s Thomas Germain became the world’s “best tech journalist at eating hot dogs”—at least, that’s what ChatGPT and Google Search’s “AI Overview” were telling Internet users for a while. Germain achieved this false glory with what he has called “the dumbest stunt” ... Show More

In this episode of Science Quickly, we’ll unpack a worrying prediction for women’s heart health that says nearly 60 percent of women in the U.S. will have some form of cardiovascular disease by 2050. We’ll also get you the latest on NASA’s upcoming historic moon missions. Plus, w ... Show More

<div>Sick people play a large role in driving antibiotic overuse. </div> 

Bacterial diseases 

<p>La résistance accrue de certains virus et bactéries aux antibiotiques est responsable d'un très grand nombre de décès. C'est que révèle une récente étude internationale, qui suggère aussi des solutions pour lutter contre cette antibiorésistance.</p><br><p>Plus d'un million de ... Show More

La phagothérapie est une méthode de traitement des infections bactériennes, qui utilise des bactériophages. Sauf exception, elle n’est plus pratiquée en occident depuis des décennies. Mais face à l’antibiorésistance, de plus en plus de médecins et chercheurs y voient une solution ... Show More

<p>In this episode I cover antibiotics.<br/><br/>If you want to follow along with written notes on bacteria go to zerotofinals.com/antibiotics/ or find the infectious diseases section in the Zero to Finals medicine book.<br/><br/>This episode covers the mechanism of action, local ... Show More

In this podcast Simon Daniel discusses Gasterophilus sp. management within an era of anthelmintic resistance. 

Weltweit sterben mehr Menschen an multiresistenten Keimen als an AIDS – Tendenz steigend. Was haben wir ihnen künftig noch entgegenzusetzen?